The preparation of deuterium labeled fexinidazole, a 5‐nitroimidazole drug candidate for the treatment of Human African Trypanosomiasis, and its two main metabolites (fexinidazole sulfoxide and fexinidazole sulfone) for use as internal standards for liquid chromatography‐mass spectrometry are report
Synthesis of 2H- and 13C-labelled sunitinib and its primary metabolite
✍ Scribed by Paul W. Elsinghorst; Michael Gütschow
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 210 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Sunitinib (Sutent^®^, Pfizer) was approved in 2006 for the treatment of gastrointestinal and renal cancer. Isotope‐labelled derivatives have already been prepared for PET and ADME radiography. The preparation of ^13^C‐ and ^2^H‐labelled internal standards of sunitinib (SU11248) and its primary metabolite (SU12662) for LC‐MS analysis of human blood samples is presented. Copyright © 2009 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract JTT‐501 specifically labelled with ^13^C was obtained __via__ a four‐step synthesis at an isotopic enrichment level of 99% and in 14% overall chemical yield starting from 4‐hydroxy‐[ring‐U‐^13^C~6~]benzaldehyde **(3)**. The hydrogenation of [^13^C~6~]JTT‐501 over Pd/C gave [^13^C~6~]JTP
## Abstract ^13^C labelled (1,2 and 1,12) and perdeuterated derivatives of 2‐phenyl cyclododecanones, as precursors for labelled triplet flexible biradicals to probe magnetic isotope effects at the radical centers on the triplet decay dynamics, were synthesized. Isotopomers of 2‐phenylcyclododecano
## Abstract Sulfamethoxazole was labelled at positions 3, 5, and 4′ by H/D exchange in a mixture of 5% ^2^H~2~SO~4~ and 95% ^2^H~2~O (v/v) under reflux for 72h with good isotope incorporation and acceptable yield. Subsequently, [^2^H~3~]‐sulfamethoxazole‐__N__~1~‐glucuronide and [^2^H~3~]‐__N__~4~‐